These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27022914)

  • 1. Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis.
    de Carvalho SS; Simões e Silva AC; Sabino Ade P; Evangelista FC; Gomes KB; Dusse LM; Rios DR
    PLoS One; 2016; 11(3):e0150613. PubMed ID: 27022914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.
    Kim DK; Kim JW; Kim S; Gwon HC; Ryu JC; Huh JE; Choo JA; Choi Y; Rhee CH; Lee WR
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3242-7. PubMed ID: 9409318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension.
    Makris TK; Stavroulakis GA; Dafni UG; Gialeraki AE; Krespi PG; Hatzizacharias AN; Tsoukala CG; Vythoulkas JS; Kyriakidis MK
    Am Heart J; 2000 Nov; 140(5):760-5. PubMed ID: 11054622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population.
    Matsubara Y; Hayakawa T; Tsuda T; Takeshita E; Watanabe G; Murata M; Watanabe K; Ikeda Y
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):115-20. PubMed ID: 10759003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension.
    Jeng JR; Harn HJ; Yueh KC; Jeng CY; Shieh SM
    Am J Hypertens; 1998 Feb; 11(2):235-9. PubMed ID: 9524054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of ACE I/D polymorphism with the levels of ACE, kallikrein, angiotensin II and interleukin-6 in STEMI patients.
    Dai S; Ding M; Liang N; Li Z; Li D; Guan L; Liu H
    Sci Rep; 2019 Dec; 9(1):19719. PubMed ID: 31873176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
    Jastrzebskal M; Widecka K; Naruszewicz M; Ciechanowicz A; Janczak-Bazan A; Foltynska A; Goracy I; Chetstowski K; Wesotowska T
    Nutr Metab Cardiovasc Dis; 2004 Oct; 14(5):259-69. PubMed ID: 15673060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms on PAI-1 and ACE genes in association with fibrinolytic bleeding after on-pump cardiac surgery.
    Ozolina A; Strike E; Nikitina-Zake L; Jaunalksne I; Krumina A; Lacis R; Bjertnaes LJ; Vanags I
    BMC Anesthesiol; 2015 Sep; 15():122. PubMed ID: 26340801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of angiotensin I-converting enzyme gene polymorphism with ACE and PAI-1 levels in Guangdong Chinese Han patients with essential hypertension].
    Zhang YL; Zhou SX; Lei J; Zhang JM
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1681-4. PubMed ID: 18024289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between the angiotensin-converting enzyme insertion/deletion polymorphism and plasminogen activator inhibitor-1 antigen levels in the National Heart, Lung, and Blood Institute Family Heart Study.
    Pankow JS; Arnett DK; Borecki IB; Hunt SC; Eckfeldt JH; Folsom AR; Djoussé L
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):551-8. PubMed ID: 10997795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of the angiotensin-converting enzyme gene in end-stage renal failure patients.
    Aucella F; Vigilante M; Margaglione M; Grandone E; del Popolo A; Forcella M; Procaccini D; Salatino G; Passione A; Ktena M; De Min A; Stallone C
    Nephron; 2000 May; 85(1):54-9. PubMed ID: 10773756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between TGF-beta-1 genotypes and microalbuminuria in essential hypertensive men.
    Dell'Omo G; Penno G; Pucci L; Lucchesi D; Del Prato S; Pedrinelli R
    Nephrol Dial Transplant; 2009 Jun; 24(6):1864-9. PubMed ID: 19176688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.
    Bora E; Soylar R; Arıkan-Ayyıldız Z; Uzuner N; Giray-Bozkaya Ö; Erçal D; Karaman Ö; Ülgenalp A
    Allergol Immunopathol (Madr); 2013; 41(1):11-6. PubMed ID: 22361338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of insertion/deletion polymorphisms of the angiotensin converting enzyme gene in Malaysian end-stage renal disease patients.
    Ali A; Vasudevan R; Ismail P; Thiam Seong CL; Chakravarthi S
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1337-43. PubMed ID: 21421653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism.
    Ishimitsu T; Tsukada K; Ohta S; Inada H; Minami J; Ono H; Matsuoka H
    Am J Kidney Dis; 2004 Sep; 44(3):466-75. PubMed ID: 15332219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Kallikrein and Angiotensin I-converting enzyme N- and C-terminal domain activities are modulated by the insertion/deletion polymorphism.
    Almeida SS; Barros CC; Moraes MR; Russo FJ; Haro AS; Rosa TS; Alves MF; Pesquero JB; Carmona AK; Bacurau RF; Araújo RC
    Neuropeptides; 2010 Apr; 44(2):139-43. PubMed ID: 20064660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.